Yoshikawa, Fukumi
Uchino, Hiroshi http://orcid.org/0000-0001-9282-918X
Nagashima, Tomoko
Usui, Shuki
Miyagi, Masahiko
Ando, Yasuyo
Hirose, Takahisa
Article History
Received: 2 January 2021
Accepted: 12 May 2021
First Online: 5 June 2021
Declarations
:
: The authors have no other relevant affiliations or financial involvement with any organizations or entities with a financial interest in or financial conflict with the subject or materials discussed in the manuscript apart from those disclosed. This study was not supported by any pertinent commercial company. Fukumi Yoshikawa, Hiroshi Uchino, Tomoko Nagashima, Shuki Usui, Masahiko Miyagi, Yasuyo Ando, and Naoki Kumashiro declare that they have no conflict of interest. Takahisa Hirose has received research support from Takeda Pharmaceutical Company Limited, Ono Pharmaceutical Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company, Limited, Sumitomo Dainippon Pharma Co., Ltd., Novo Nordisk Pharma Ltd., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Taisho Pharmaceutical Co., Ltd. Astellas Pharma Inc. Takahisa Hirose has received advisory panel and research support from Nippon Boehringer Ingelheim Co., Ltd., AstraZeneca K.K., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Pharma Ltd., and speaker honoraria from, Sanofi K.K. Eli Lilly Japan K.K., Novo Nordisk Pharma Ltd., Takeda Pharmaceutical Company Limited, MSD K.K., Sumitomo Dainippon Pharma Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Ono Pharmaceutical Co., Ltd., AstraZeneca K.K., Mitsubishi Tanabe Pharma Corporation, Kowa Company, Limited, and Kissei Pharmaceutical Co., Ltd.
: All procedures performed in the study involving human participants were in accordance with the Ethical Committee of Toho University School of Medicine, Tokyo, Japan (No 91-23, 22/Jan/2016) and with the 1964 Helsinki Declaration and its later amendments. Informed consent was obtained from all individual participants included in the study.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
: Some of the findings from this study were presented at the 77th Scientific Sessions of American Diabetes Association, June 9–13, 2017, San Diego, California.